Bowel prep combination

PreclinicalSmall molecule

MMedtronic - MITG

Bowel prep combination is one of 4 small molecule programs targeting Endoscopy. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

EndoscopyTerminated

EndoscopyPreclinical

Terminated

Competition

Competitive Landscape

4 competitors in Endoscopy

#DrugCompanyPhaseTrials

Reglan

IIstituto Clinico Humanitas

Preclinical

2 2

Domperidone

Johnson & Johnson

Preclinical

1 3

Bowel prep combination

MMedtronic - MITG

Preclinical

1 4

Indigo Carmine

HHillel Yaffe Medical Center

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Endoscopy1 trial

Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers ("HEIGHT" Study)

Terminated·MMedtronic - MITG·N/A·NCT03301909·694 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Bowel prep combination. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Bowel prep combination compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Bowel prep combination. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Medtronic - MITG company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: MMedtronic - MITG

Bowel prep combination

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Endoscopy1 trial

References

Drug Info

Quick Facts

Related News